BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 9393309)

  • 1. A possible explanation of wet and dry nights in enuretic children.
    Hansen AF; Jørgensen TM
    Br J Urol; 1997 Nov; 80(5):809-11. PubMed ID: 9393309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of small functional bladder capacity and other predictors on the response to desmopressin in the management of monosymptomatic nocturnal enuresis.
    Rushton HG; Belman AB; Zaontz MR; Skoog SJ; Sihelnik S
    J Urol; 1996 Aug; 156(2 Pt 2):651-5. PubMed ID: 8683752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced anti-diuretic response to desmopressin during wet nights in patients with monosymptomatic nocturnal enuresis.
    Tauris LH; Andersen RF; Kamperis K; Hagstroem S; Rittig S
    J Pediatr Urol; 2012 Jun; 8(3):285-90. PubMed ID: 21514237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term home studies of water balance in patients with nocturnal enuresis.
    Rittig S; Schaumburg H; Schmidt F; Hunsballe JM; Hansen AF; Kirk J; Vestergaard P; Djurhuus JC
    Scand J Urol Nephrol Suppl; 1997; 183():25-6; discussion 26-7. PubMed ID: 9165600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of DDAVP is related to the circadian rhythm of urine output in patients with persisting nocturnal enuresis.
    Hunsballe JM; Hansen TK; Rittig S; Pedersen EB; Djurhuus JC
    Clin Endocrinol (Oxf); 1998 Dec; 49(6):793-801. PubMed ID: 10209568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial response to intranasal desmopressin in children with monosymptomatic nocturnal enuresis is related to persistent nocturnal polyuria on wet nights.
    Raes A; Dehoorne J; Van Laecke E; Hoebeke P; Vande Walle C; Vansintjan P; Donckerwolcke R; Vande Walle J
    J Urol; 2007 Sep; 178(3 Pt 1):1048-51; discussion 1051-2. PubMed ID: 17632162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alarm interventions for nocturnal enuresis in children.
    Caldwell PH; Codarini M; Stewart F; Hahn D; Sureshkumar P
    Cochrane Database Syst Rev; 2020 May; 5(5):CD002911. PubMed ID: 32364251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of primary monosymptomatic nocturnal enuresis with desmopressin: predictive factors.
    Kruse S; Hellström AL; Hanson E; Hjälmås K; Sillén U;
    BJU Int; 2001 Oct; 88(6):572-6. PubMed ID: 11678753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to desmopressin as a function of urine osmolality in the treatment of monosymptomatic nocturnal enuresis: a double-blind prospective study.
    Rushton HG; Belman AB; Zaontz M; Skoog SJ; Sihelnik S
    J Urol; 1995 Aug; 154(2 Pt 2):749-53. PubMed ID: 7609170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desmopressin resistant enuresis: pathogenetic and therapeutic considerations.
    Nevéus T; Läckgren G; Tuvemo T; Olsson U; Stenberg A
    J Urol; 1999 Dec; 162(6):2136-40. PubMed ID: 10569604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desmopressin for nocturnal enuresis in children.
    Glazener CM; Evans JH
    Cochrane Database Syst Rev; 2000; 2002(2):CD002112. PubMed ID: 10796860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral desmopressin: a randomized double-blind placebo controlled study of effectiveness in children with primary nocturnal enuresis.
    Skoog SJ; Stokes A; Turner KL
    J Urol; 1997 Sep; 158(3 Pt 2):1035-40. PubMed ID: 9258137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination treatment of nocturnal enuresis with desmopressin and indomethacin.
    Kamperis K; Hagstroem S; Faerch M; Mahler B; Rittig S; Djurhuus JC
    Pediatr Nephrol; 2017 Apr; 32(4):627-633. PubMed ID: 27787700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desmopressin for nocturnal enuresis in children.
    Glazener CM; Evans JH
    Cochrane Database Syst Rev; 2002; (3):CD002112. PubMed ID: 12137645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Frequently recurring' nocturnal polyuria is predictive of response to desmopressin in monosymptomatic nocturnal enuresis in childhood.
    Marzuillo P; Marotta R; Guarino S; Fedele MC; Palladino F; Capalbo D; Della Vecchia N; Miraglia Del Giudice E; Polito C; La Manna A
    J Pediatr Urol; 2019 Apr; 15(2):166.e1-166.e7. PubMed ID: 30528650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective randomized trial using laser acupuncture versus desmopressin in the treatment of nocturnal enuresis.
    Radmayr C; Schlager A; Studen M; Bartsch G
    Eur Urol; 2001 Aug; 40(2):201-5. PubMed ID: 11528199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional bladder capacity as predictor of response to desmopressin and retention control training in monosymptomatic nocturnal enuresis.
    Hamano S; Yamanishi T; Igarashi T; Ito H; Murakami S
    Eur Urol; 2000 Jun; 37(6):718-22. PubMed ID: 10828674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desmopressin versus indomethacin treatment in primary nocturnal enuresis and the role of prostaglandins.
    Sener F; Hasanoğlu E; Söylemezoğlu O
    Urology; 1998 Nov; 52(5):878-81. PubMed ID: 9801119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased renal concentrating ability after long-term oral desmopressin lyophilisate treatment contributes to continued success for monosymptomatic nocturnal enuresis.
    Ikeda H; Watanabe T; Isoyama K
    Int J Urol; 2017 Sep; 24(9):698-702. PubMed ID: 28636262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nocturnal enuresis and daytime wetting: a multicentric trial with oxybutynin and desmopressin.
    Caione P; Arena F; Biraghi M; Cigna RM; Chendi D; Chiozza ML; De Lisa A; De Grazia E; Fano M; Formica P; Garofalo S; Gramenzi R; von Heland M; Lanza P; Lanza T; Maffei S; Manieri C; Merlini E; Miano L; Nappo S; Pagliarulo A; Paolini Paoletti F; Pau AC; Porru D; Artibani W
    Eur Urol; 1997; 31(4):459-63. PubMed ID: 9187908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.